Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 27;428(2-3):53-8.
doi: 10.1016/j.neulet.2007.09.058. Epub 2007 Oct 2.

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels

Laila Abdullah  1 , Daniel Paris, Cheryl Luis, Amita Quadros, Julia Parrish, Luis Valdes, Andrew P Keegan, Venkatarajan Mathura, Fiona Crawford, Michael Mullan
Affiliations

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels

Laila Abdullah et al. Neurosci Lett. .

Abstract

Evidence suggests that high peripheral beta-amyloid (Abeta)(1-40) levels and low ratios of Abeta(1-42)/Abeta(1-40) are associated with increased risk for Alzheimer's disease (AD). In this cross-sectional design, serum and plasma samples from 67 AD patients and 146 controls (similar in age and gender) were evaluated using Abeta(1-40) and Abeta(1-42) ELISA. Coefficient of variance was calculated for intra- and inter-person variability of Abeta(1-40) and Abeta(1-42). Abeta(1-40) correlated with age, MMSE and their Abeta(1-42)/Abeta(1-40) ratios (p<0.05). Significantly higher Abeta(1-40) levels were observed in AD patients than controls (p<0.05) but no difference was observed for Abeta(1-42) (p>0.05). Serum Abeta(1-42)/Abeta(1-40) ratios were also significantly lower in AD patients than controls (p<0.05). Lower intra-person than inter-person variability was observed for serum and plasma Abeta(1-40) and Abeta(1-42) and these were higher in controls than in AD patients. The intra-person variability of serum Abeta(1-40) did not influence the group differences observed between AD patients and controls. Significant interaction was observed between diagnosis and intra-person variability for serum Abeta(1-40) levels (p<0.05) and was supported by our finding of higher intra-person variability for serum Abeta(1-40) in controls (26.97%) than in AD patients (18.35%). We confirm the previously observed differences in blood Abeta levels between AD and control groups. In addition, we now report the presence of high intra- and inter-person variability possibly due to factors that influence peripheral Abeta levels and warrant further investigation before the potential use of Abeta as an AD biomarker can be fully exploited.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources